138 related articles for article (PubMed ID: 9293481)
1. In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression.
Moretti S; Pinzi C; Berti E; Spallanzani A; Chiarugi A; Boddi V; Reali UM; Giannotti B
Melanoma Res; 1997 Aug; 7(4):313-21. PubMed ID: 9293481
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-associated expression of transforming growth factor-beta isoforms.
Van Belle P; Rodeck U; Nuamah I; Halpern AC; Elder DE
Am J Pathol; 1996 Jun; 148(6):1887-94. PubMed ID: 8669474
[TBL] [Abstract][Full Text] [Related]
3. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
Schmid P; Itin P; Rufli T
Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
[TBL] [Abstract][Full Text] [Related]
4. Progression-related expression of beta3 integrin in melanomas and nevi.
Van Belle PA; Elenitsas R; Satyamoorthy K; Wolfe JT; Guerry D; Schuchter L; Van Belle TJ; Albelda S; Tahin P; Herlyn M; Elder DE
Hum Pathol; 1999 May; 30(5):562-7. PubMed ID: 10333228
[TBL] [Abstract][Full Text] [Related]
5. Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype.
Janji B; Melchior C; Gouon V; Vallar L; Kieffer N
Int J Cancer; 1999 Oct; 83(2):255-62. PubMed ID: 10471536
[TBL] [Abstract][Full Text] [Related]
6. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.
Altomonte M; Montagner R; Fonsatti E; Colizzi F; Cattarossi I; Brasoveanu LI; Nicotra MR; Cattelan A; Natali PG; Maio M
Br J Cancer; 1996 Nov; 74(10):1586-91. PubMed ID: 8932339
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions.
Moretti S; Pinzi C; Spallanzani A; Berti E; Chiarugi A; Mazzoli S; Fabiani M; Vallecchi C; Herlyn M
Int J Cancer; 1999 Apr; 84(2):160-8. PubMed ID: 10096249
[TBL] [Abstract][Full Text] [Related]
8. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
[TBL] [Abstract][Full Text] [Related]
9. Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions.
Moretti S; Massobrio R; Brogelli L; Novelli M; Giannotti B; Bernengo MG
J Invest Dermatol; 1990 Sep; 95(3):320-4. PubMed ID: 1696603
[TBL] [Abstract][Full Text] [Related]
10. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
11. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.
Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM
Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
[TBL] [Abstract][Full Text] [Related]
13. Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro.
Schadendorf D; Worm M; Jurgovsky K; Dippel E; Reichert U; Czarnetzki BM
Recent Results Cancer Res; 1995; 139():183-93. PubMed ID: 7597289
[TBL] [Abstract][Full Text] [Related]
14. Beta3 integrin expression in melanoma predicts subsequent metastasis.
Hieken TJ; Farolan M; Ronan SG; Shilkaitis A; Wild L; Das Gupta TK
J Surg Res; 1996 Jun; 63(1):169-73. PubMed ID: 8661192
[TBL] [Abstract][Full Text] [Related]
15. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas.
Kondoh M; Ueda M; Ichihashi M; Mishima Y
Melanoma Res; 1993 Aug; 3(4):241-5. PubMed ID: 8219756
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
19. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
